Changes in subcellular localization reveal interactions between human cytomegalovirus terminase subunits

Virology Journal

Volumn 9, Issue , 2012, Pages

  Wang, Jian Ben ^a   Zhu, Yali ^b   McVoy, Michael A ^a   Parris, Deborah S ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Cytomegalovirus; DNA packaging; Genome maturation; Herpesvirus; Terminase

Indexed keywords

HUMAN CYTOMEGALOVIRUS TERMINASE; UL51 PROTEIN; UL56 PROTEIN; UL89 PROTEIN; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL NUCLEUS; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INSECT CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VIRUS CELL INTERACTION;

ACTIVE TRANSPORT, CELL NUCLEUS; BACULOVIRIDAE; CELL NUCLEUS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOPLASM; DNA PACKAGING; DNA REPLICATION; DNA, VIRAL; GENETIC VECTORS; HEK293 CELLS; HUMANS; MICROSCOPY, CONFOCAL; PROTEIN INTERACTION MAPPING; SF9 CELLS; TRANSFECTION; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HEXAPODA; HUMAN HERPESVIRUS 5; MIRIDAE; SIMPLEXVIRUS;

EID: 84871378194     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-315     Document Type: Article

References (34)

1. Packaging DNA into Herpesvirus Capsids. Brown JC, McVoy MA, Homa FL, Structure-Function Relationships of Human Pathogenic Viruses London: Kluwer Academic/Plenum Publishers, Bogner E, Holzenburg A, 2002
2. ATPase activity of the terminase subunit pUL56 of human cytomegalovirus. Hwang JS, Bogner E, J Biol Chem 2002 277 6943 6948 10.1074/jbc.M108984200 11744697 (Pubitemid 34953080)
3. Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus. Thoma C, Borst E, Messerle M, Rieger M, Hwang JS, Bogner E, Biochemistry 2006 45 8855 8863 10.1021/bi0600796 16846228 (Pubitemid 44100681)
4. The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89. Borst EM, Kleine-Albers J, Gabaev I, Babic M, Wagner K, Binz A, Degenhardt I, Kalesse M, Jonjic S, Bauerfeind R, Messerle M, J Virol 2012 [Epub ahead of print]
5. The pseudorabies virus UL28 protein enters the nucleus after coexpression with the herpes simplex virus UL15 protein. Koslowski KM, Shaver PR, Wang XY, Tenney DJ, Pederson NE, J Virol 1997 71 9118 9123 9371568 (Pubitemid 27492351)
6. Physical and functional interactions between the herpes simplex virus UL15 and UL28 DNA cleavage and packaging proteins. Koslowski KM, Shaver PR, Casey JT 2nd, Wilson T, Yamanaka G, Sheaffer AK, Tenney DJ, Pederson NE, J Virol 1999 73 1704 1707 9882384 (Pubitemid 29036834)
7. Interaction of the herpes simplex virus type 1 packaging protein UL15 with full-length and deleted forms of the UL28 protein. Abbotts AP, Preston VG, Hughes M, Patel AH, Stow ND, J Gen Virol 2000 81 2999 3009 11086131 (Pubitemid 32000647)
8. DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells. Beard PM, Taus NS, Baines JD, J Virol 2002 76 4785 4791 10.1128/JVI.76.10.4785-4791. 2002 11967295 (Pubitemid 34441684)
9. The putative terminase subunit of herpes simplex virus 1 encoded by UL28 is necessary and sufficient to mediate interaction between pUL15 and pUL33. Yang K, Baines JD, J Virol 2006 80 5733 5739 10.1128/JVI.00125-06 16731912 (Pubitemid 43849151)
10. Characterization of pseudorabies virus (PrV) cleavage-encapsidation proteins and functional complementation of PrV pUL32 by the homologous protein of herpes simplex virus type 1. Fuchs W, Klupp BG, Granzow H, Leege T, Mettenleiter TC, J Virol 2009 83 3930 3943 10.1128/JVI.02636-08 19193798
11. Temperature-sensitive mutations in the putative herpes simplex virus type 1 terminase subunits pUL15 and pUL33 preclude viral DNA cleavage/packaging and interaction with pUL28 at the nonpermissive temperature. Yang K, Poon AP, Roizman B, Baines JD, J Virol 2008 82 487 494 10.1128/JVI.01875-07 17913813 (Pubitemid 350309162)
12. Linker insertion mutations in the herpes simplex virus type 1 UL28 gene: effects on UL28 interaction with UL15 and UL33 and identification of a second-site mutation in the UL15 gene that suppresses a lethal UL28 mutation. Jacobson JG, Yang K, Baines JD, Homa FL, J Virol 2006 80 12312 12323 10.1128/JVI.01766-06 17035316 (Pubitemid 44904381)
13. Mutational analysis of the herpes simplex virus type 1 DNA packaging protein UL33. Beilstein F, Higgs MR, Stow ND, J Virol 2009 83 8938 8945 10.1128/JVI.01048-09 19553324
14. Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins. Visalli RJ, Knepper J, Goshorn B, Vanover K, Burnside DM, Irven K, McGauley R, Visalli M, Virus Res 2009 144 58 64 10.1016/j.virusres.2009.03.019 19720242
15. The Varicella-zoster virus DNA encapsidation genes: Identification and characterization of the putative terminase subunits. Visalli RJ, Nicolosi DM, Irven KL, Goshorn B, Khan T, Visalli MA, Virus Res 2007 129 200 211 10.1016/j.virusres.2007.07.015 17868947 (Pubitemid 47588437)
16. Herpesviral protein networks and their interaction with the human proteome. Uetz P, Dong YA, Zeretzke C, Atzler C, Baiker A, Berger B, Rajagopala SV, Roupelieva M, Rose D, Fossum E, Haas J, Science 2006 311 239 242 10.1126/science.1116804 16339411 (Pubitemid 43108191)
17. Evolutionarily conserved herpesviral protein interaction networks. Fossum E, Friedel CC, Rajagopala SV, Titz B, Baiker A, Schmidt T, Kraus T, Stellberger T, Rutenberg C, Suthram S, et al. PLoS Pathog 2009 5 1000570 10.1371/journal.ppat.1000570 19730696
18. The potential terminase subunit of human cytomegalovirus, pUL56, is translocated into the nucleus by its own nuclear localization signal and interacts with importin alpha. Giesen K, Radsak K, Bogner E, J Gen Virol 2000 81 2231 2244 10950981
19. Targeting of the gene product encoded by ORF UL56 of human cytomegalovirus into viral replication centers. Giesen K, Radsak K, Bogner E, FEBS Lett 2000 471 215 218 10.1016/S0014-5793(00)01407-1 10767426 (Pubitemid 30190069)
20. Varicella zoster virus ORF25 gene product: an essential hub protein linking encapsidation proteins and the nuclear egress complex. Vizoso Pinto MG, Pothineni VR, Haase R, Woidy M, Lotz-Havla AS, Gersting SW, Muntau AC, Haas J, Sommer M, Arvin AM, Baiker A, J Proteome Res 2011 10 5374 5382 10.1021/pr200628s 21988664
21. Identification of Proteins in Human Cytomegalovirus (HCMV) Particles: the HCMV Proteome. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DG 2nd, Rodland K, Wiley S, et al. J Virol 2004 78 10960 10966 10.1128/JVI.78.20.10960-10966.2004 15452216 (Pubitemid 39299636)
22. Identification of proteins associated with murine cytomegalovirus virions. Kattenhorn LM, Mills R, Wagner M, Lomsadze A, Makeev V, Borodovsky M, Ploegh HL, Kessler BM, J Virol 2004 78 11187 11197 10.1128/JVI.78.20.11187- 11197.2004 15452238 (Pubitemid 39299658)
23. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. Underwood MR, Harvey RJ, Stanat SC, Hemphill ML, Miller T, Drach JC, Townsend LB, Biron KK, J Virol 1998 72 717 725 9420278 (Pubitemid 28048891)
24. Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus. Underwood MR, Ferris RG, Selleseth DW, Davis MG, Drach JC, Townsend LB, Biron KK, Boyd FL, Antimicrob Agents Chemother 2004 48 1647 1651 10.1128/AAC.48.5.1647-1651.2004 15105116 (Pubitemid 38544370)
25. A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. Buerger I, Reefschlaeger J, Bender W, Eckenberg P, Popp A, Weber O, Graeper S, Klenk HD, Ruebsamen-Waigmann H, Hallenberger S, J Virol 2001 75 9077 9086 10.1128/JVI.75.19.9077-9086.2001 11533171 (Pubitemid 32851912)
26. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. Krosky PM, Underwood MR, Turk SR, Feng KW, Jain RK, Ptak RG, Westerman AC, Biron KK, Townsend LB, Drach JC, J Virol 1998 72 4721 4728 9573236 (Pubitemid 28215647)
27. Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene. van Zeijl M, Fairhurst J, Jones TR, Vernon SK, Morin J, LaRocque J, Feld B, O'Hara B, Bloom JD, Johann SV, J Virol 2000 74 9054 9061 10.1128/JVI.74.19.9054-9061.2000 10982350
28. Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomegalovirus. Hwang JS, Kregler O, Schilf R, Bannert N, Drach JC, Townsend LB, Bogner E, J Virol 2007 81 11604 11611 10.1128/JVI.01130-07 17728228 (Pubitemid 47623792)
29. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. Goldner T, Hewlett G, Ettischer N, Ruebsamen-Schaeff H, Zimmermann H, Lischka P, J Virol 2011 85 10884 10893 10.1128/JVI.05265-11 21752907
30. Antiviral strategies to combat cytomegalovirus infections in transplant recipients. Lischka P, Zimmermann H, Curr Opin Pharmacol 2008 8 541 548 10.1016/j.coph.2008.07.002 18662804
31. In vitro evaluation of the activities of the novel anti-cytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses. Marschall M, Stamminger T, Urban A, Wildum S, Ruebsamen-Schaeff H, Zimmermann H, Lischka P, Antimicrob Agents Chemother 2011 56 2 1135 1137 22106211
32. Antiviral treatment of cytomegalovirus infection: an update. Harter G, Michel D, Expert Opin Pharmacother 2012 13 623 627 10.1517/14656566.2012.658775 22299626
33. Flightless-I, a gelsolin family member and transcriptional regulator, preferentially binds directly to activated cytosolic CaMK-II. Seward ME, Easley CA, McLeod JJ, Myers AL, Tombes RM, FEBS Lett 2008 582 2489 2495 10.1016/j.febslet.2008.06.037 18588881
34. Evidence against a simple tethering model for enhancement of herpes simplex virus DNA polymerase processivity by accessory protein UL42. Chaudhuri M, Parris DS, J Virol 2002 76 10270 10281 10.1128/JVI.76.20.10270-10281.2002 12239303